Dawson, L. A., Winter, K. A., Knox, J. J., Zhu, A. X., Krishnan, S., Guha, C., Kachnic, L. A., Gillin, M. T., Hong, T. S., Craig, T. D., Williams, T. M., Hosni, A., Chen, E., Noonan, A. M., Koay, E. J., Sinha, R., Lock, M. I., Ohri, N., Dorth, J. A., … Crane, C. H. (2024). Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2024.5403

Unger, J. M., Till, C., Tangen, C. M., Hershman, D. L., Goodman, P. J., LeBlanc, M., Barlow, W. E., Vaidya, R., Minasian, L. M., Parnes, H. L., & Thompson, I. M. (2024). Long-Term Adverse Effects and Complications After Prostate Cancer Treatment. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2024.4397

Muchtar, E., Wisniowski, B., Geyer, S., Palladini, G., Milani, P., Merlini, G., Schönland, S., Veelken, K., Hegenbart, U., Leung, N., Dispenzieri, A., Kumar, S. K., Kastritis, E., Dimopoulos, M. A., Liedtke, M., Ulloa, P., Sanchorawala, V., Szalat, R., Dooley, K., … Gertz, M. A. (2024). Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2024.2629

Blackford, A. L., Canto, M. I., Dbouk, M., Hruban, R. H., Katona, B. W., Chak, A., Brand, R. E., Syngal, S., Farrell, J., Kastrinos, F., Stoffel, E. M., Rustgi, A., Klein, A. P., Kamel, I., Fishman, E. K., He, J., Burkhart, R., Shin, E. J., Lennon, A. M., & Goggins, M. (2024). Pancreatic Cancer Surveillance and Survival of High-Risk Individuals. JAMA Oncology, 10(8), 1087. https://doi.org/10.1001/jamaoncol.2024.1930

Lee, H., Bates, A. S., Callier, S., Chan, M., Chambwe, N., Marshall, A., Terry, M. B., Winkfield, K., & Janowitz, T. (2024). Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time. JAMA Oncology, 10(5), 652. https://doi.org/10.1001/jamaoncol.2023.7314

Trivedi, M. S., & Armstrong, K. A. (2024). Increasing the Uptake of Cancer Risk Management Strategies for Women With BRCA1/2 Sequence Variations. JAMA Oncology, 10(4), 435. https://doi.org/10.1001/jamaoncol.2023.5186

Manji, G. A., Lee, S., Del Portillo, A., May, M., Ana, S. S., Alouani, E., Sender, N., Negri, T., Gautier, K., Ge, L., Fan, W., Xie, M., Sethi, A., Schrope, B., Tan, A. C., Park, H., Oberstein, P. E., Shah, M. A., & Raufi, A. G. (2023). Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction Adenocarcinoma. JAMA Oncology, 9(12), 1702. https://doi.org/10.1001/jamaoncol.2023.4423

Kinslow, C. J., Cheng, S. K., & Wang, T. J. C. (2023). MGMT Promoter Methylation and Chemotherapy Outcomes in Low-Grade and Anaplastic Gliomas—Reply. JAMA Oncology, 9(12), 1735. https://doi.org/10.1001/jamaoncol.2023.4754

Necchi, A., Faltas, B. M., Slovin, S. F., Meeks, J. J., Pal, S. K., Schwartz, L. H., Huang, R. S. P., Li, R., Manley, B., Chahoud, J., Ross, J. S., & Spiess, P. E. (2023). Immunotherapy in the Treatment of Localized Genitourinary Cancers. JAMA Oncology, 9(10), 1447. https://doi.org/10.1001/jamaoncol.2023.2174

Labadie, B. W., & Fojo, A. T. (2023). In Defense of Neuroendocrine Tumor Trials—Reply. JAMA Oncology, 9(10), 1464. https://doi.org/10.1001/jamaoncol.2023.3395

Unger, J. M., Xiao, H., Vaidya, R., LeBlanc, M., & Hershman, D. L. (2023). Medicaid Expansion of the Patient Protection and Affordable Care Act and Participation of Patients With Medicaid in Cancer Clinical Trials. JAMA Oncology, 9(10), 1371. https://doi.org/10.1001/jamaoncol.2023.2800

Matsuo, K., Mandelbaum, R. S., Vallejo, A., Klar, M., Roman, L. D., & Wright, J. D. (2023). Assessment of Gender-Specific COVID-19 Case Fatality Risk per Malignant Neoplasm Type. JAMA Oncology, 9(8), 1113. https://doi.org/10.1001/jamaoncol.2023.0768

Kinslow, C. J., Mercurio, A., Kumar, P., Rae, A. I., Siegelin, M. D., Grinband, J., Taparra, K., Upadhyayula, P. S., McKhann, G. M., Sisti, M. B., Bruce, J. N., Canoll, P. D., Iwamoto, F. M., Kachnic, L. A., Yu, J. B., Cheng, S. K., & Wang, T. J. C. (2023). Association of MGMT Promoter Methylation With Survival in Low-grade and Anaplastic Gliomas After Alkylating Chemotherapy. JAMA Oncology, 9(7), 919. https://doi.org/10.1001/jamaoncol.2023.0990

Ryu, S., Deshmukh, S., Timmerman, R. D., Movsas, B., Gerszten, P., Yin, F.-F., Dicker, A., Abraham, C. D., Zhong, J., Shiao, S. L., Tuli, R., Desai, A., Mell, L. K., Iyengar, P., Hitchcock, Y. J., Allen, A. M., Burton, S., Brown, D., Sharp, H. J., … Kachnic, L. A. (2023). Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine. JAMA Oncology, 9(6), 800. https://doi.org/10.1001/jamaoncol.2023.0356

Serrano, D., Gandini, S., Thomas, P., Crew, K. D., Kumar, N. B., Vornik, L. A., Lee, J. J., Veronesi, P., Viale, G., Guerrieri-Gonzaga, A., Lazzeroni, M., Johansson, H., D’Amico, M., Guasone, F., Spinaci, S., Bertelsen, B.-E., Mellgren, G., Bedrosian, I., Weber, D., … Bonanni, B. (2023). Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor–Positive Breast Cancer. JAMA Oncology, 9(5), 664. https://doi.org/10.1001/jamaoncol.2023.0089

Labadie, B. W., & Fojo, A. T. (2023). Requirements for Meaningful Progress in the Therapy of Neuroendocrine Cancers. JAMA Oncology, 9(5), 606. https://doi.org/10.1001/jamaoncol.2022.7842

Chen, S., Cao, Z., Prettner, K., Kuhn, M., Yang, J., Jiao, L., Wang, Z., Li, W., Geldsetzer, P., Bärnighausen, T., Bloom, D. E., & Wang, C. (2023). Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050. JAMA Oncology, 9(4), 465. https://doi.org/10.1001/jamaoncol.2022.7826

Liau, L. M., Ashkan, K., Brem, S., Campian, J. L., Trusheim, J. E., Iwamoto, F. M., Tran, D. D., Ansstas, G., Cobbs, C. S., Heth, J. A., Salacz, M. E., D’Andre, S., Aiken, R. D., Moshel, Y. A., Nam, J. Y., Pillainayagam, C. P., Wagner, S. A., Walter, K. A., Chaudhary, R., … Bosch, M. L. (2023). Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma. JAMA Oncology, 9(1), 112. https://doi.org/10.1001/jamaoncol.2022.5370

Bakouny, Z., Labaki, C., Grover, P., Awosika, J., Gulati, S., Hsu, C.-Y., Alimohamed, S. I., Bashir, B., Berg, S., Bilen, M. A., Bowles, D., Castellano, C., Desai, A., Elkrief, A., Eton, O. E., Fecher, L. A., Flora, D., Galsky, M. D., Gatti-Mays, M. E., … Stratton, C. (2023). Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19. JAMA Oncology, 9(1), 128. https://doi.org/10.1001/jamaoncol.2022.5357

Mullangi, S., Aviki, E. M., & Hershman, D. L. (2022). Reexamining Social Determinants of Health Data Collection in the COVID-19 Era. JAMA Oncology, 8(12), 1736. https://doi.org/10.1001/jamaoncol.2022.4543

Kinslow, C. J., Kim, A., Sanchez, G. I., Cheng, S. K., Kachnic, L. A., Neugut, A. I., & Horowitz, D. P. (2022). Incidence of Anaplastic Large-Cell Lymphoma of the Breast in the US, 2000 to 2018. JAMA Oncology, 8(9), 1354. https://doi.org/10.1001/jamaoncol.2022.2624

Ricciuti, B., Wang, X., Alessi, J. V., Rizvi, H., Mahadevan, N. R., Li, Y. Y., Polio, A., Lindsay, J., Umeton, R., Sinha, R., Vokes, N. I., Recondo, G., Lamberti, G., Lawrence, M., Vaz, V. R., Leonardi, G. C., Plodkowski, A. J., Gupta, H., Cherniack, A. D., … Awad, M. M. (2022). Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels. JAMA Oncology, 8(8), 1160. https://doi.org/10.1001/jamaoncol.2022.1981

Matsuo, K., Klar, M., Youssefzadeh, A. C., Mandelbaum, R. S., Roman, L. D., Ouzounian, J. G., & Wright, J. D. (2022). Assessment of Severe Maternal Morbidity and Mortality in Pregnancies Complicated by Cancer in the US. JAMA Oncology, 8(8), 1213. https://doi.org/10.1001/jamaoncol.2022.1795

Zeng, C., Bastarache, L. A., Tao, R., Venner, E., Hebbring, S., Andujar, J. D., Bland, H. T., Crosslin, D. R., Pratap, S., Cooley, A., Pacheco, J. A., Christensen, K. D., Perez, E., Zawatsky, C. L. B., Witkowski, L., Zouk, H., Weng, C., Leppig, K. A., Sleiman, P. M. A., … Denny, J. C. (2022). Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases. JAMA Oncology, 8(6), 835. https://doi.org/10.1001/jamaoncol.2022.0373

Tong, W. (2022). Differently. JAMA Oncology, 8(6), 951. https://doi.org/10.1001/jamaoncol.2022.0156

Tong, W. (2022). Please Say Hi to Grandpa for Us. JAMA Oncology, 8(2), 308. https://doi.org/10.1001/jamaoncol.2021.5978

Dercle, L., Zhao, B., Gönen, M., Moskowitz, C. S., Firas, A., Beylergil, V., Connors, D. E., Yang, H., Lu, L., Fojo, T., Carvajal, R., Karovic, S., Maitland, M. L., Goldmacher, G. V., Oxnard, G. R., Postow, M. A., & Schwartz, L. H. (2022). Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis. JAMA Oncology, 8(3), 385. https://doi.org/10.1001/jamaoncol.2021.6818

Tong, W. (2022). A Flash of Gold and Glitter. JAMA Oncology, 8(1), 173. https://doi.org/10.1001/jamaoncol.2021.5096

Melamed, A., Rauh-Hain, J. A., Gockley, A. A., Nitecki, R., Ramirez, P. T., Hershman, D. L., Keating, N., & Wright, J. D. (2021). Association Between Overall Survival and the Tendency for Cancer Programs to Administer Neoadjuvant Chemotherapy for Patients With Advanced Ovarian Cancer. JAMA Oncology, 7(12), 1782. https://doi.org/10.1001/jamaoncol.2021.4252